# L.B. von Kobyletzki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/l-b-von-kobyletzki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 831 |
| Field | Dermatology and Skin Diseases |
| h-index | 12 |
| i10-index | 12 |
| Last Known Institution | Örebro University |
| OpenAlex ID | https://openalex.org/A5113878721 |
| Works | 14 |

## Researcher papers

- [Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement](https://scholariq.org/papers/patient-oriented-eczema-measure-poem-a-core-instrument-to-measure-symptoms-in/)
- [Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)](https://scholariq.org/papers/report-from-the-fourth-international-consensus-meeting-to-harmonize-core-outcome/)
- [European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis](https://scholariq.org/papers/european-task-force-on-atopic-dermatitis-statement-on-severe-acute-respiratory/)
- [Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema ( <scp>RECAP</scp> )](https://scholariq.org/papers/development-and-initial-testing-of-a-new-instrument-to-measure-the-experience-of/)
- [Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review](https://scholariq.org/papers/evaluation-of-the-measurement-properties-of-symptom-measurement-instruments-for/)
- [What Factors are Important to Patients when Assessing Treatment Response: An International Cross-sectional Survey](https://scholariq.org/papers/what-factors-are-important-to-patients-when-assessing-treatment-response-an/)
- [European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis](https://scholariq.org/papers/european-task-force-on-atopic-dermatitis-etfad-treatment-targets-and-treatable/)
- [European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics](https://scholariq.org/papers/european-task-force-on-atopic-dermatitis-position-on-vaccination-of-adult/)
- [Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts](https://scholariq.org/papers/risk-of-severe-allergic-reactions-to-covid-19-vaccines-among-patients-with/)
- [TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema](https://scholariq.org/papers/treatment-of-atopic-eczema-treat-registry-taskforce-protocol-for-a-european/)
- [Quality of Life and Economic Burden in Swedish Adults with Atopic Dermatitis: A Cross-sectional Survey of Patientreported Outcomes](https://scholariq.org/papers/quality-of-life-and-economic-burden-in-swedish-adults-with-atopic-dermatitis-a/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Delphi Technique in Research](https://scholariq.org/topics/delphi-technique-in-research/)

## Researcher university

- [Örebro University](https://scholariq.org/institutions/orebro-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.